Peduzzi, Giulia
Archibugi, Livia
Katzke, Verena
Gentiluomo, Manuel
Capurso, Gabriele
Milanetto, Anna Caterina
Gazouli, Maria
Goetz, Mara
Brenner, Hermann
Vermeulen, Roel C. H.
Talar-Wojnarowska, Renata
Vanella, Giuseppe
Tavano, Francesca
Lucchesi, Maurizio
Mohelnikova-Duchonova, Beatrice
Chen, Xuechen
Kiudelis, Vytautas
Hegyi, Péter
Oliverius, Martin
Stocker, Hannah
Stornello, Caterina
Vodickova, Ludmila
Souček, Pavel
Neoptolemos, John P.
Testoni, Sabrina Gloria Giulia
Morelli, Luca
Lawlor, Rita T.
Basso, Daniela
Izbicki, Jakob R.
Ermini, Stefano
Kupcinskas, Juozas
Pezzilli, Raffaele
Boggi, Ugo
van Laarhoven, Hanneke W. M.
Szentesi, Andrea
Erőss, Bálint
Capretti, Giovanni
Schöttker, Ben
Skieceviciene, Jurgita
Aoki, Mateus Nóbrega
van Eijck, Casper H. J.
Cavestro, Giulia Martina
Canzian, Federico
Campa, Daniele
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 2021-ID. 26201 project)
Czech Health Research Council (NV19-03-00097)
AZV (NU21-07-00247)
Operational Programme Integrated Infrastructure (IMTS: 313011V446)
European Regional Development Fund (IMTS: 313011V446)
National operation Programm: National Institute for cancer research (LX22NPO05102)
Intramural funding of DKFZ
Fondazione Tizzi
Fondazione Arpa
Article History
Received: 20 July 2022
Accepted: 21 October 2022
First Online: 27 October 2022
Competing interests
: HWML has acted as a consultant for BMS, Daiichy, Eli Lilly and Company, MSD, Nordic Pharma Group/Taiho, and Servier, and has received unrestricted research grants from Amgen, Bayer Schering Pharma AG, BMS, Celgene, Eli Lilly and Company, GlaxoSmithKline Pharmaceuticals, Merck, MSD, Nordic Pharma Group, Philips, and Roche Pharmaceuticals.